Sanbo Hospital Management Group Limited (SHE:301293)
China · Delayed Price · Currency is CNY 48.80
-0.43 (-0.87%)
At close: Sep 15, 2026
SHE:301293 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Total Valuation
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
| 9,971 | 11,972 | 8,785 | 9,891 | - | - | |
Market Cap Growth | -19.21% | 36.27% | -11.17% | - | - | - |
Enterprise Value | 10,571 | 12,325 | 7,906 | 8,639 | - | - |
Last Close Price | 49.12 | 58.98 | 43.15 | 47.78 | - | - |
Price Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
PE Ratio | 213.35 | 142.22 | 83.65 | 126.42 | - | - |
PS Ratio | 5.33 | 6.94 | 6.15 | 7.53 | - | - |
PB Ratio | 3.76 | 4.53 | 3.34 | 3.94 | - | - |
P/TBV Ratio | 6.10 | 7.50 | 5.68 | 5.51 | - | - |
P/FCF Ratio | - | - | - | 130.14 | - | - |
P/OCF Ratio | 41.43 | 63.59 | 54.27 | 40.28 | - | - |
EV Ratios
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
EV/Sales Ratio | 5.66 | 7.14 | 5.53 | 6.58 | - | - |
EV/EBITDA Ratio | 42.85 | 54.59 | 42.82 | 50.21 | - | - |
EV/EBIT Ratio | 91.40 | 84.50 | 56.57 | 67.07 | - | - |
EV/FCF Ratio | - | - | - | 113.68 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Debt / Equity Ratio | 0.28 | 0.25 | 0.12 | 0.07 | 0.17 | 0.22 |
Debt / EBITDA Ratio | 3.06 | 2.64 | 1.43 | 0.90 | 1.34 | 1.39 |
Debt / FCF Ratio | - | - | - | 2.45 | 3.70 | - |
Net Debt / Equity Ratio | 0.12 | 0.08 | -0.17 | -0.56 | -0.27 | -0.23 |
Net Debt / EBITDA Ratio | 1.43 | 0.96 | -2.43 | -8.13 | -2.70 | -1.72 |
Net Debt / FCF Ratio | -1.57 | -0.54 | 1.18 | -18.40 | -5.99 | 12.33 |
Asset Turnover | 0.49 | 0.46 | 0.43 | 0.52 | 0.57 | 0.69 |
Inventory Turnover | 25.70 | 22.65 | 25.77 | 32.37 | 27.89 | 30.18 |
Quick Ratio | 1.21 | 0.99 | 1.57 | 3.81 | 2.00 | 2.23 |
Current Ratio | 1.37 | 1.14 | 1.73 | 3.92 | 2.17 | 2.41 |
Return on Equity (ROE) | 0.72% | 2.74% | 4.50% | 4.35% | 5.90% | 7.29% |
Return on Assets (ROA) | 1.89% | 2.45% | 2.62% | 3.17% | 3.08% | 4.59% |
Return on Invested Capital (ROIC) | 1.19% | 3.50% | 6.49% | 8.71% | 7.30% | 12.07% |
Return on Capital Employed (ROCE) | 3.40% | 4.40% | 4.70% | 4.80% | 5.70% | 8.10% |
Yields
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 14, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Earnings Yield | 0.47% | 0.70% | 1.20% | 0.79% | - | - |
FCF Yield | -2.06% | -3.33% | -4.32% | 0.77% | - | - |
Dividend Yield | 0.30% | - | 0.34% | 0.15% | - | - |
Payout Ratio | 85.51% | 43.35% | 14.33% | 0.71% | 0.83% | 1.24% |
Buyback Yield / Dilution | -0.41% | 0.30% | -7.92% | -22.62% | -0.73% | -2.59% |
Total Shareholder Return | -0.11% | 0.30% | -7.58% | -22.47% | -0.73% | -2.59% |